Investitionsthese
Clarma Capital invests in European life sciences startups driving transformative healthcare innovation, focusing on differentiated products, strategic exits, and operational growth support through collaboration with management teams and industry stakeholders.
Investitionsphase
Early-stage
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Early-stage European Life Sciences startups with regulated products, addressable markets, and strong commercial management teams
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€250.000 - €1.000.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (10)
A
Alain Bindels
Venture Partner
C
Clara Ezed
Partner
D
Dr. László Szabó
M.D. Venture Partner
M
Martyn Eeles
Managing Partner & Founder
M
Martyn Eeles(Hungary, United Kingdom)
Partner
M
Mary Jo Gorman
Senior Advisor
M
Mary Jo Gorman, MD
Senior Advisor
M
Milos Milicsevics
Partner
O
Okeibuno Okonkwo
Senior Advisor
O
Okeibuno Okonkwo, MD
Senior Advisor
